241 related articles for article (PubMed ID: 8411386)
1. Activation of a heterologous promoter by human immunodeficiency virus type 1 Tat requires Sp1 and is distinct from the mode of activation by acidic transcriptional activators.
Kamine J; Subramanian T; Chinnadurai G
J Virol; 1993 Nov; 67(11):6828-34. PubMed ID: 8411386
[TBL] [Abstract][Full Text] [Related]
2. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
Kamine J; Subramanian T; Chinnadurai G
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
[TBL] [Abstract][Full Text] [Related]
3. Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1.
Kamine J; Chinnadurai G
J Virol; 1992 Jun; 66(6):3932-6. PubMed ID: 1583736
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
5. The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat.
Lu X; Welsh TM; Peterlin BM
J Virol; 1993 Apr; 67(4):1752-60. PubMed ID: 8445708
[TBL] [Abstract][Full Text] [Related]
6. Transactivation of heterologous promoters by HIV-1 tat.
Han P; Brown R; Barsoum J
Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814
[TBL] [Abstract][Full Text] [Related]
7. Core promoter specificities of the Sp1 and VP16 transcriptional activation domains.
Emami KH; Navarre WW; Smale ST
Mol Cell Biol; 1995 Nov; 15(11):5906-16. PubMed ID: 7565743
[TBL] [Abstract][Full Text] [Related]
8. Increased spacing between Sp1 and TATAA renders human immunodeficiency virus type 1 replication defective: implication for Tat function.
Huang LM; Jeang KT
J Virol; 1993 Dec; 67(12):6937-44. PubMed ID: 8230415
[TBL] [Abstract][Full Text] [Related]
9. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
10. Recruitment of the TATA-binding protein to the HIV-1 promoter is a limiting step for Tat transactivation.
Majello B; Napolitano G; Lania L
AIDS; 1998 Oct; 12(15):1957-64. PubMed ID: 9814863
[TBL] [Abstract][Full Text] [Related]
11. Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo.
Veschambre P; Simard P; Jalinot P
J Mol Biol; 1995 Jul; 250(2):169-80. PubMed ID: 7608968
[TBL] [Abstract][Full Text] [Related]
12. Promoter activity of Tat at steps subsequent to TATA-binding protein recruitment.
Xiao H; Lis JT; Jeang KT
Mol Cell Biol; 1997 Dec; 17(12):6898-905. PubMed ID: 9372921
[TBL] [Abstract][Full Text] [Related]
13. Synergism between Tat and VP16 in trans-activation of HIV-1 LTR.
Ghosh S; Selby MJ; Peterlin BM
J Mol Biol; 1993 Dec; 234(3):610-9. PubMed ID: 8254663
[TBL] [Abstract][Full Text] [Related]
14. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat.
Berkhout B; Jeang KT
J Virol; 1992 Jan; 66(1):139-49. PubMed ID: 1727476
[TBL] [Abstract][Full Text] [Related]
15. ZFX transactivation of the HIV-1 LTR is cell specific and depends on core enhancer and TATA box sequences.
Gazin C
Nucleic Acids Res; 1999 May; 27(10):2156-64. PubMed ID: 10219088
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression.
Olsen HS; Rosen CA
J Virol; 1992 Sep; 66(9):5594-7. PubMed ID: 1501293
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner.
Suñé C; Garcia-Blanco MA
Mol Cell Biol; 1999 Jul; 19(7):4719-28. PubMed ID: 10373521
[TBL] [Abstract][Full Text] [Related]
18. Wild-type and transactivation-defective mutants of human immunodeficiency virus type 1 Tat protein bind human TATA-binding protein in vitro.
Wang Z; Morris GF; Rice AP; Xiong W; Morris CB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):128-38. PubMed ID: 8680883
[TBL] [Abstract][Full Text] [Related]
19. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
Tiley LS; Madore SJ; Malim MH; Cullen BR
Genes Dev; 1992 Nov; 6(11):2077-87. PubMed ID: 1427073
[TBL] [Abstract][Full Text] [Related]
20. Interactions between Tat of HIV-2 and transcription factor Sp1.
Pagtakhan AS; Tong-Starksen SE
Virology; 1997 Nov; 238(2):221-30. PubMed ID: 9400595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
